KITS Eyecare Accelerates Growth with 21.6% Revenue Surge in Q3 2026…

Event summary

Q3 2026 revenue grew 21.6% year-over-year to $63.7 million, surpassing a $250 million annualized run-rate for the first time.
Glasses revenue surged 59.3% year-over-year to $11.3 million, accelerating from 54.0% growth in Q2 2026.
Preliminary Adjusted EBITDA exceeded 4.5% of revenue, or $2.9 million, despite continued investment in glasses growth and marketing.
Cash increased by $3.2 million to $30.6 million, with no debt on the balance sheet.

The big picture

KITS Eyecare's Q3 2026 results highlight its successful vertical integration strategy, combining digital platform capabilities with in-house lens manufacturing. The company's ability to grow revenue while maintaining a strong cash position and no debt positions it favorably in the competitive eyecare market. The acceleration in glasses revenue suggests a diversified growth trajectory beyond its core contact lens business, which could attract investors focused on scalable, digitally-native healthcare models.

What we're watching

Glasses Revenue Growth: Whether KITS can sustain the nearly 60% year-over-year growth in glasses revenue as it becomes a second growth engine alongside contacts.
Profitability Dynamics: How the company will balance continued investment in growth initiatives with maintaining or improving its adjusted EBITDA margin.
Customer Retention: The pace at which KITS can improve its net revenue retention rates, particularly for more recent customer cohorts.